Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
So what: Revenues were up 13.1% to $321.6 million in the quarter, net income came in at $40.1 million, and adjusted earnings per share were $0.20. All results were higher than last year, even with client delays affecting revenue.
Now what: The company won 20 new clients in the quarter and reported a solid sales pipeline, but revenues fell short of expectations. I don't think this is a reason to panic, and it gives a long-term investor a good entry point to buy the stock. Growing sales and an earnings beat are always good in this Fool's eyes.
Interested in more info on Genpact? Add it to your watchlist by clicking here.